Benfotiamine

Generic Name
Benfotiamine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H23N4O6PS
CAS Number
22457-89-2
Unique Ingredient Identifier
Y92OUS2H9B
Background

Benfotiamine has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.

Associated Conditions
Thiamine Deficiency
Associated Therapies
-
Clinical Trials
Related News

Benfotiamine in Alzheimer's Disease: A Pilot Study

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Benfotiamine
First Posted Date
2014-11-17
Last Posted Date
2022-06-28
Lead Sponsor
Burke Medical Research Institute
Target Recruit Count
71
Registration Number
NCT02292238
Locations
🇺🇸

Burke, White Plains, New York, United States

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

First Posted Date
2013-06-04
Last Posted Date
2013-06-04
Lead Sponsor
Diabetes Schwerpunktpraxis
Target Recruit Count
22
Registration Number
NCT01868191
Locations
🇩🇪

Diabetes Schwerpunktpraxis, Essen, NRW, Germany

Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers

Phase 3
Completed
Conditions
Healthy Subjects
Interventions
Drug: Benfotiamine
First Posted Date
2008-11-05
Last Posted Date
2008-11-05
Lead Sponsor
Ruhr University of Bochum
Target Recruit Count
20
Registration Number
NCT00785460
Locations
🇩🇪

Heart and Diabetes Center, Bad Oeynhausen, NRW, Germany

High Dose Vitamin B1 to Reduce Abusive Alcohol Use

Phase 4
Completed
Conditions
Alcoholism
Interventions
Drug: Placebo
Drug: Benfotiamine
First Posted Date
2008-05-19
Last Posted Date
2014-09-25
Lead Sponsor
University of Kansas
Target Recruit Count
120
Registration Number
NCT00680121
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Benfotiamine in Diabetic Nephropathy

Phase 4
Completed
Conditions
Diabetic Nephropathy
Interventions
Drug: Placebo
Drug: Benfotiamine
First Posted Date
2007-11-29
Last Posted Date
2009-11-16
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
86
Registration Number
NCT00565318
Locations
🇳🇱

Isala Klinieken Hospital, Zwolle, Netherlands

Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus

First Posted Date
2007-03-13
Last Posted Date
2007-09-27
Lead Sponsor
Ruhr University of Bochum
Target Recruit Count
30
Registration Number
NCT00446810
Locations
🇩🇪

Herz- und Diabeteszentrum NRW, Georgstr. 11, Bad Oeynhausen, North Rhine-Westphalia, Germany

Effects of Vitamin B1 in Type 1 Diabetic Patients

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Drug: Placebo
Drug: Benfotiamine
First Posted Date
2005-07-04
Last Posted Date
2013-05-10
Lead Sponsor
University Hospital, Aker
Target Recruit Count
67
Registration Number
NCT00117026
Locations
🇳🇴

Aker University Hospital, Oslo, Norway

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy